Shares of Larimar Therapeutics (NASDAQ:LRMR) gained on Wednesday after Oppenheimer launched the company with an Outperform recommendation, citing the potential of its lead asset, nomlabofusp, targeted ...
On Wednesday, Larimar Therapeutics Inc (LRMR) stock saw a modest uptick, ending the day at $7.71 which represents a slight increase of $0.29 or 3.91% from the prior close of $7.42. The stock opened at ...
Oppenheimer has initiated coverage on Larimar Therapeutics, emphasizing its lead program Nomlabofusp as a transformative therapy for Friedreich's ataxia. With a price target of $26, the company plans ...
Shares of Larimar Therapeutics (NASDAQ:LRMR) gained on Wednesday after Oppenheimer launched the company with an Outperform recommendation, citing the potential of its lead asset, nomlabofusp ...
Larimar Therapeutics' CTI-1601, a potential first-in-class treatment for Friedreich's ataxia, shows promise in modifying disease progression and restoring mitochondrial function. The company has a ...
The best all-inclusive resorts in Punta Cana allow travelers to have it all without having to pull out a credit card while on vacation. Here are our top picks for 2024.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...